Seock-Ah Im

机构：Seoul National University, New Generation University College, Seoul National University Hospital

发表论文 19 篇 · 总被引 367 次 · h-index 9

代表论文

• Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study (2019 · Journal of Global Oncology · 被引 78)
• Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial (2016 · BMC Cancer · 被引 63)
• Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts (2021 · Nature Communications · 被引 55)
• Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer (2025 · New England Journal of Medicine · 被引 50)
• Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies (2020 · Breast Cancer Research · 被引 39)
• TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer (2025 · Therapeutic Advances in Medical Oncology · 被引 27)